2020
DOI: 10.1016/j.bioorg.2020.103725
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, anticancer evaluation and molecular docking studies of new heterocycles linked to sulfonamide moiety as novel human topoisomerase types I and II poisons

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
16
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 32 publications
(17 citation statements)
references
References 52 publications
1
16
0
Order By: Relevance
“…Notably, compound 18 was able to intercalate the DNA double helix similarly to that of the co‐crystallized inhibitor ( ASW ), which recommends it to be a potential DNA intercalator besides a promising topoisomerase II inhibitor as well, Table 3. Docking results of VEGFR2 and Topo II inhibition agreed with some previous studies [20,29] with the same target inhibition for benzene sulfonamide moieties, besides the experimental results of both targets′ inhibition of these newly synthesized derivatives.…”
Section: Resultssupporting
confidence: 88%
“…Notably, compound 18 was able to intercalate the DNA double helix similarly to that of the co‐crystallized inhibitor ( ASW ), which recommends it to be a potential DNA intercalator besides a promising topoisomerase II inhibitor as well, Table 3. Docking results of VEGFR2 and Topo II inhibition agreed with some previous studies [20,29] with the same target inhibition for benzene sulfonamide moieties, besides the experimental results of both targets′ inhibition of these newly synthesized derivatives.…”
Section: Resultssupporting
confidence: 88%
“…The multidrug-resistant phenotype in cancer that mediates MDR also heavily relies on P-glycoprotein (P-gp/ABCB1) [29]. Based on our ongoing experiences to create effective anticancer benzochromenebased medicines, [30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47][48], we have initiated the current study. Developing drugs with potential anti-proliferative activity against three cancer cell lines, PC-3, SKOV-3 and HeLa, while having no cytotoxic effect on normal cell lines HFL-1 and WI-38, was the main motivation behind our decision to design and synthesize β-enaminonitriles incorporating a 9-hydroxy-1H-benzo[f]chromene moiety.…”
Section: Introductionmentioning
confidence: 99%
“…In continuation of our efforts to discover oxygen-heterocyclic derivatives with promising antimicrobial and antitumor activities [41][42][43][44][45][46][47][48][49][50][51][52][53][54][55][56][57], we present the synthesis of 3-amino-1-(4-chlorophenyl)-9-methoxy-1H-benzo[f ]chromene-2-carbonitrile and portray its crystallographic structure. Moreover, the antimicrobial behavior of the target molecule is evaluated and its minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and minimum fungicidal concentrations (MFC) are appraised.…”
Section: Introductionmentioning
confidence: 99%